Black Diamond Therapeutics Inc. (BDTX) NASDAQ
$4.94 (0.12) (-2.37%)
Market Cap: $261.69M
As of 04/25/24 10:17 AM EDT. Market open.
Black Diamond Therapeutics Inc. (BDTX)
NASDAQ
$4.94
(0.12) (-2.37%)
Market Cap: $261.69M
As of 04/25/24 10:17 AM EDT. Market open.
black diamond therapeutics, inc., a precision oncology medicine company, discovers and develops small molecule, tumor-agnostic therapies. its lead product candidate is bdtx-189, an inhibitor of non-canonical and oncogenic mutations of erbb kinases epidermal growth factor receptor (egfr) and tyrosine-protein kinase. the company is also developing allosteric-egfr mutation inhibitors; and various ... read more
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Behbahani Ali | Director | Mar 15, 2024 | Option Exercise | $4.54 | 3,166 | 14,374 | 51,690 | Apr 03, 2024, 09:00 PM |
DIXON WENDY L | Director | Mar 15, 2024 | Option Exercise | $4.54 | 3,253 | 14,769 | 38,054 | Apr 03, 2024, 08:49 PM |
Behbahani Ali | Director | Dec 15, 2023 | Option Exercise | $2.73 | 4,455 | 12,162 | 48,524 | Dec 15, 2023, 04:48 PM |
DIXON WENDY L | Director | Dec 15, 2023 | Option Exercise | $2.73 | 4,043 | 11,037 | 34,801 | Dec 15, 2023, 04:40 PM |
BIOTECH GROWTH N V | 10% Owner | Oct 17, 2023 | Buy | $2.34 | 400,000 | 934,080 | 8,517,839 | Oct 19, 2023, 03:08 PM |
Behbahani Ali | Director | Sep 15, 2023 | Option Exercise | $3.60 | 3,299 | 11,876 | 44,069 | Sep 18, 2023, 05:34 PM |
Velleca Mark A. | PRESIDENT & CEO | Sep 15, 2023 | Option Exercise | $3.60 | 5,208 | 18,749 | 46,522 | Sep 18, 2023, 05:26 PM |
DIXON WENDY L | Director | Sep 15, 2023 | Option Exercise | $3.60 | 2,986 | 10,750 | 30,758 | Sep 18, 2023, 05:25 PM |
RA CAPITAL MANAGEMENT, L.P. | Director | Jul 05, 2023 | Buy | $5.00 | 935,850 | 4,679,250 | 3,213,828 | Jul 07, 2023, 04:30 PM |
Behbahani Ali | Director | Jul 05, 2023 | Buy | $5.00 | 1,000,000 | 5,000,000 | 4,448,757 | Jul 06, 2023, 04:45 PM |
BIOTECH GROWTH N V | 10% Owner | Jun 30, 2023 | Buy | $5.00 | 1,000,000 | 5,000,000 | 8,117,839 | Jul 03, 2023, 03:36 PM |
BIOTECH GROWTH N V | 10% Owner | Jun 27, 2023 | Buy | $5.49 | 1,740,000 | 9,555,036 | 7,117,839 | Jun 29, 2023, 01:37 PM |
Epstein David M. | SEE REMARKS | Jun 27, 2023 | Sale | $6.70 | 25,000 | 167,500 | 671,423 | Jun 28, 2023, 04:02 PM |
Behbahani Ali | Director | Jun 16, 2023 | Option Exercise | $2.10 | 5,655 | 11,875 | 40,770 | Jun 16, 2023, 06:42 PM |
DIXON WENDY L | Director | Jun 16, 2023 | Option Exercise | $2.10 | 5,119 | 10,750 | 27,772 | Jun 16, 2023, 05:41 PM |
Velleca Mark A. | Director | Jun 16, 2023 | Option Exercise | $2.10 | 8,929 | 18,751 | 41,314 | Jun 16, 2023, 05:41 PM |
Behbahani Ali | Director | Mar 16, 2023 | Option Exercise | $1.67 | 7,111 | 11,875 | 35,115 | Mar 20, 2023, 04:41 PM |
DIXON WENDY L | Director | Mar 16, 2023 | Option Exercise | $1.67 | 6,437 | 10,750 | 22,653 | Mar 20, 2023, 04:34 PM |
Velleca Mark A. | Director | Mar 16, 2023 | Option Exercise | $1.67 | 11,228 | 18,751 | 32,385 | Mar 20, 2023, 04:33 PM |
Ni Fang | SEE REMARKS | Dec 21, 2022 | Buy | $1.29 | 20,000 | 25,770 | 89,026 | Dec 23, 2022, 04:23 PM |
Ni Fang | SEE REMARKS | Dec 22, 2022 | Buy | $1.28 | 36,363 | 46,596 | 125,389 | Dec 23, 2022, 04:23 PM |
Behbahani Ali | Director | Dec 16, 2022 | Option Exercise | $1.50 | 7,917 | 11,876 | 28,004 | Dec 19, 2022, 09:27 PM |
Velleca Mark A. | Director | Dec 16, 2022 | Option Exercise | $1.50 | 8,424 | 12,636 | 21,157 | Dec 19, 2022, 09:16 PM |
DIXON WENDY L | Director | Dec 16, 2022 | Option Exercise | $1.50 | 7,167 | 10,751 | 16,216 | Dec 19, 2022, 09:15 PM |
INGRAM ROBERT ALEXANDER | FORMER DIRECTOR | Dec 16, 2022 | Option Exercise | $1.50 | 9,375 | 14,063 | 42,854 | Dec 19, 2022, 09:14 PM |
BIOTECH GROWTH N V | 10% Owner | Oct 31, 2022 | Buy | $2.25 | 99,801 | 224,912 | 5,377,839 | Nov 02, 2022, 03:10 PM |
BIOTECH GROWTH N V | 10% Owner | Oct 28, 2022 | Buy | $2.18 | 172,974 | 376,962 | 5,278,038 | Oct 31, 2022, 03:20 PM |
BIOTECH GROWTH N V | 10% Owner | Oct 27, 2022 | Buy | $1.87 | 191,678 | 359,224 | 5,105,064 | Oct 31, 2022, 03:20 PM |
BIOTECH GROWTH N V | 10% Owner | Oct 21, 2022 | Buy | $1.51 | 87,850 | 132,750 | 4,913,386 | Oct 25, 2022, 04:24 PM |
BIOTECH GROWTH N V | 10% Owner | Oct 20, 2022 | Buy | $1.42 | 53,734 | 76,345 | 4,825,536 | Oct 21, 2022, 03:06 PM |
BIOTECH GROWTH N V | 10% Owner | Oct 19, 2022 | Buy | $1.32 | 77,689 | 102,775 | 4,771,802 | Oct 21, 2022, 03:06 PM |
Behbahani Ali | Director | Sep 16, 2022 | Option Exercise | $2.62 | 4,532 | 11,874 | 20,087 | Sep 19, 2022, 06:39 PM |
DIXON WENDY L | Director | Sep 16, 2022 | Option Exercise | $2.62 | 4,103 | 10,750 | 9,049 | Sep 19, 2022, 05:10 PM |
Velleca Mark A. | Director | Sep 16, 2022 | Option Exercise | $2.62 | 4,294 | 11,250 | 12,733 | Sep 19, 2022, 05:09 PM |
INGRAM ROBERT ALEXANDER | Director | Sep 16, 2022 | Option Exercise | $2.62 | 6,584 | 17,250 | 33,479 | Sep 19, 2022, 05:08 PM |
DIXON WENDY L | Director | Jun 17, 2022 | Option Exercise | $2.03 | 4,946 | 10,040 | 4,946 | Jun 30, 2022, 04:07 PM |
Ni Fang | SEE REMARKS | Jun 29, 2022 | Buy | $2.44 | 25,000 | 61,018 | 69,026 | Jun 30, 2022, 04:05 PM |
Behbahani Ali | Director | Jun 17, 2022 | Option Exercise | $2.03 | 5,850 | 11,875 | 15,555 | Jun 17, 2022, 04:35 PM |
Velleca Mark A. | Director | Jun 17, 2022 | Option Exercise | $2.03 | 5,542 | 11,250 | 8,439 | Jun 17, 2022, 04:27 PM |
DIXON WENDY L | Director | Jun 17, 2022 | Option Exercise | $2.03 | 4,060 | 8,242 | 4,060 | Jun 17, 2022, 04:26 PM |
INGRAM ROBERT ALEXANDER | Director | Jun 17, 2022 | Option Exercise | $2.03 | 8,498 | 17,251 | 26,895 | Jun 17, 2022, 04:25 PM |
BIOTECH GROWTH N V | 10% Owner | Apr 28, 2022 | Buy | $2.57 | 255,711 | 657,868 | 4,694,113 | Apr 29, 2022, 10:50 AM |
BIOTECH GROWTH N V | 10% Owner | Apr 27, 2022 | Buy | $2.66 | 150,000 | 399,480 | 4,438,402 | Apr 29, 2022, 10:50 AM |
BIOTECH GROWTH N V | 10% Owner | Apr 19, 2022 | Buy | $3.24 | 150,000 | 486,645 | 4,288,402 | Apr 20, 2022, 12:56 PM |
BIOTECH GROWTH N V | 10% Owner | Apr 18, 2022 | Buy | $3.29 | 150,000 | 493,935 | 4,138,402 | Apr 20, 2022, 12:56 PM |
BIOTECH GROWTH N V | 10% Owner | Apr 13, 2022 | Buy | $3.57 | 102,556 | 366,217 | 3,988,402 | Apr 14, 2022, 12:09 PM |
BIOTECH GROWTH N V | 10% Owner | Apr 12, 2022 | Buy | $3.42 | 150,000 | 513,600 | 3,885,846 | Apr 14, 2022, 12:09 PM |
Behbahani Ali | Director | Mar 18, 2022 | Option Exercise | $3.02 | 4,346 | 13,125 | 9,705 | Mar 18, 2022, 04:15 PM |
INGRAM ROBERT ALEXANDER | Director | Mar 18, 2022 | Option Exercise | $3.02 | 5,795 | 17,501 | 18,397 | Mar 18, 2022, 04:05 PM |
Velleca Mark A. | Director | Mar 18, 2022 | Option Exercise | $3.02 | 2,897 | 8,749 | 2,897 | Mar 18, 2022, 04:05 PM |
Behbahani Ali | Director | Dec 17, 2021 | Option Exercise | $5.31 | 2,472 | 13,126 | 5,359 | Dec 17, 2021, 04:50 PM |
INGRAM ROBERT ALEXANDER | Director | Dec 17, 2021 | Option Exercise | $5.31 | 3,296 | 17,502 | 12,602 | Dec 17, 2021, 04:12 PM |
Behbahani Ali | Director | Sep 17, 2021 | Option Exercise | $9.90 | 1,326 | 13,127 | 2,887 | Sep 23, 2021, 05:43 PM |
INGRAM ROBERT ALEXANDER | Director | Sep 17, 2021 | Option Exercise | $9.90 | 1,869 | 18,503 | 9,306 | Sep 23, 2021, 05:33 PM |
INGRAM ROBERT ALEXANDER | Director | Jun 18, 2021 | Option Exercise | $12.95 | 1,255 | 16,252 | 7,437 | Jun 22, 2021, 06:13 PM |
Hatzis-Schoch Brent | See Remarks | May 12, 2021 | Option Exercise | $3.20 | 4,078 | 13,050 | 12,478 | May 13, 2021, 04:53 PM |
Hatzis-Schoch Brent | See Remarks | May 12, 2021 | Sale | $27.42 | 4,078 | 111,805 | 11,317 | May 13, 2021, 04:53 PM |
Roberts Christopher D. | Chief Scientific Officer | May 03, 2021 | Option Exercise | $10.86 | 2,500 | 27,150 | 5,700 | May 05, 2021, 04:31 PM |
Roberts Christopher D. | Chief Scientific Officer | May 03, 2021 | Sale | $26.64 | 2,500 | 66,602 | 3,200 | May 05, 2021, 04:31 PM |
Hatzis-Schoch Brent | See Remarks | Apr 12, 2021 | Option Exercise | $3.20 | 4,078 | 13,050 | 12,478 | Apr 13, 2021, 08:45 PM |
Hatzis-Schoch Brent | See Remarks | Apr 12, 2021 | Sale | $25.00 | 4,078 | 101,950 | 8,400 | Apr 13, 2021, 08:45 PM |
Shah Rajeev M. | Director | Apr 01, 2021 | Option Exercise | $24.26 | 353,814 | 8,583,528 | 2,277,978 | Apr 05, 2021, 04:34 PM |
Behbahani Ali | Director | Mar 18, 2021 | Option Exercise | $24.01 | 547 | 13,133 | 547 | Mar 22, 2021, 08:33 PM |
Shah Rajeev M. | Director | Mar 18, 2021 | Option Exercise | $24.01 | 443 | 10,636 | 443 | Mar 22, 2021, 08:25 PM |
INGRAM ROBERT ALEXANDER | Director | Mar 18, 2021 | Option Exercise | $24.01 | 677 | 16,255 | 6,182 | Mar 22, 2021, 08:19 PM |
Hatzis-Schoch Brent | See Remarks | Mar 12, 2021 | Option Exercise | $3.20 | 4,078 | 13,050 | 12,478 | Mar 16, 2021, 04:56 PM |
Hatzis-Schoch Brent | See Remarks | Mar 12, 2021 | Sale | $26.36 | 4,078 | 107,493 | 8,400 | Mar 16, 2021, 04:56 PM |
Roberts Christopher D. | Chief Scientific Officer | Mar 03, 2021 | Option Exercise | $10.86 | 2,500 | 27,150 | 5,700 | Mar 04, 2021, 05:52 PM |
Roberts Christopher D. | Chief Scientific Officer | Mar 03, 2021 | Sale | $26.10 | 2,500 | 65,262 | 4,084 | Mar 04, 2021, 05:52 PM |
Hatzis-Schoch Brent | See Remarks | Feb 12, 2021 | Option Exercise | $3.20 | 4,078 | 13,050 | 12,478 | Feb 12, 2021, 09:24 PM |
Hatzis-Schoch Brent | See Remarks | Feb 12, 2021 | Sale | $27.23 | 4,078 | 111,025 | 8,707 | Feb 12, 2021, 09:24 PM |
Roberts Christopher D. | Chief Scientific Officer | Feb 03, 2021 | Option Exercise | $10.86 | 2,500 | 27,150 | 5,700 | Feb 04, 2021, 05:47 PM |
Roberts Christopher D. | Chief Scientific Officer | Feb 03, 2021 | Sale | $25.35 | 2,500 | 63,375 | 3,200 | Feb 04, 2021, 05:47 PM |
Hatzis-Schoch Brent | See Remarks | Jan 12, 2021 | Option Exercise | $8.16 | 11,578 | 94,500 | 19,978 | Jan 14, 2021, 08:57 PM |
Hatzis-Schoch Brent | See Remarks | Jan 12, 2021 | Sale | $34.03 | 11,578 | 394,041 | 17,930 | Jan 14, 2021, 08:57 PM |
Leggett Thomas | Chief Financial Officer | Jan 08, 2021 | Option Exercise | $10.86 | 3,000 | 32,580 | 3,000 | Jan 11, 2021, 05:59 PM |
Leggett Thomas | Chief Financial Officer | Jan 08, 2021 | Sale | $33.94 | 3,000 | 101,820 | 0 | Jan 11, 2021, 05:59 PM |
Roberts Christopher D. | Chief Scientific Officer | Jan 04, 2021 | Option Exercise | $10.86 | 2,500 | 27,150 | 5,700 | Jan 06, 2021, 06:27 PM |
Roberts Christopher D. | Chief Scientific Officer | Jan 04, 2021 | Sale | $31.41 | 2,500 | 78,525 | 3,737 | Jan 06, 2021, 06:27 PM |
Epstein David M. | See Remarks | Jan 04, 2021 | Option Exercise | $6.42 | 3,000 | 19,260 | 708,423 | Jan 06, 2021, 06:21 PM |
Epstein David M. | See Remarks | Jan 04, 2021 | Sale | $31.13 | 12,000 | 373,505 | 698,438 | Jan 06, 2021, 06:21 PM |
Hatzis-Schoch Brent | See Remarks | Dec 28, 2020 | Option Exercise | $3.20 | 5,400 | 17,280 | 8,400 | Dec 29, 2020, 04:46 PM |
INGRAM ROBERT ALEXANDER | Director | Dec 15, 2020 | Option Exercise | $34.29 | 505 | 17,316 | 5,505 | Dec 16, 2020, 07:42 PM |
Roberts Christopher D. | Chief Scientific Officer | Dec 15, 2020 | Option Exercise | $10.86 | 3,200 | 34,752 | 3,200 | Dec 16, 2020, 07:42 PM |
Hatzis-Schoch Brent | See Remarks | Dec 14, 2020 | Option Exercise | $3.20 | 4,078 | 13,050 | 7,078 | Dec 16, 2020, 07:41 PM |
Hatzis-Schoch Brent | See Remarks | Dec 14, 2020 | Sale | $34.95 | 4,078 | 142,522 | 3,000 | Dec 16, 2020, 07:41 PM |
Epstein David M. | See Remarks | Dec 15, 2020 | Option Exercise | $6.42 | 2,500 | 16,050 | 705,423 | Dec 16, 2020, 07:39 PM |
Leggett Thomas | Chief Financial Officer | Dec 08, 2020 | Option Exercise | $10.86 | 3,000 | 32,580 | 3,000 | Dec 10, 2020, 04:16 PM |
Leggett Thomas | Chief Financial Officer | Dec 08, 2020 | Sale | $33.78 | 3,000 | 101,327 | 1,941 | Dec 10, 2020, 04:16 PM |
Roberts Christopher D. | Chief Scientific Officer | Dec 03, 2020 | Option Exercise | $10.86 | 2,500 | 27,150 | 2,500 | Dec 04, 2020, 04:34 PM |
Roberts Christopher D. | Chief Scientific Officer | Dec 03, 2020 | Sale | $32.42 | 2,500 | 81,055 | 0 | Dec 04, 2020, 04:34 PM |
Epstein David M. | See Remarks | Dec 01, 2020 | Option Exercise | $6.42 | 3,000 | 19,260 | 714,923 | Dec 03, 2020, 04:17 PM |
Epstein David M. | See Remarks | Dec 01, 2020 | Sale | $32.71 | 12,000 | 392,574 | 704,000 | Dec 03, 2020, 04:17 PM |
Bolzon Bradley J PhD | Director | Nov 30, 2020 | Sale | $33.15 | 10,393 | 344,513 | 874,299 | Dec 01, 2020, 07:13 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 30, 2020 | Sale | $33.15 | 10,393 | 344,513 | 874,299 | Dec 01, 2020, 07:13 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 19, 2020 | Sale | $33.01 | 114,854 | 3,791,330 | 4,818,600 | Nov 23, 2020, 04:41 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 19, 2020 | Sale | $33.01 | 15,163 | 500,531 | 968,954 | Nov 23, 2020, 04:41 PM |
Bolzon Bradley J PhD | Director | Nov 19, 2020 | Sale | $33.01 | 130,017 | 4,291,861 | 4,818,600 | Nov 23, 2020, 04:39 PM |
Bolzon Bradley J PhD | Director | Nov 18, 2020 | Sale | $33.09 | 536 | 17,738 | 4,933,454 | Nov 19, 2020, 09:19 PM |
Bolzon Bradley J PhD | Director | Nov 17, 2020 | Sale | $33.05 | 4,194 | 138,611 | 4,933,927 | Nov 19, 2020, 09:19 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 18, 2020 | Sale | $33.09 | 473 | 15,653 | 4,933,454 | Nov 19, 2020, 09:19 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 18, 2020 | Sale | $33.09 | 63 | 2,085 | 984,117 | Nov 19, 2020, 09:19 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 17, 2020 | Sale | $33.05 | 3,705 | 122,450 | 4,933,927 | Nov 19, 2020, 09:19 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 17, 2020 | Sale | $33.05 | 489 | 16,161 | 984,180 | Nov 19, 2020, 09:19 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 16, 2020 | Sale | $33.01 | 177 | 5,843 | 4,937,632 | Nov 17, 2020, 07:33 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 16, 2020 | Sale | $33.01 | 23 | 759 | 984,669 | Nov 17, 2020, 07:33 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 13, 2020 | Sale | $33.77 | 3,975 | 134,253 | 4,939,311 | Nov 17, 2020, 07:33 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 13, 2020 | Sale | $33.77 | 525 | 17,731 | 984,890 | Nov 17, 2020, 07:33 PM |
Bolzon Bradley J PhD | Director | Nov 16, 2020 | Sale | $33.01 | 200 | 6,603 | 4,937,632 | Nov 17, 2020, 07:28 PM |
Bolzon Bradley J PhD | Director | Nov 13, 2020 | Sale | $33.77 | 4,500 | 151,984 | 4,939,311 | Nov 17, 2020, 07:28 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 12, 2020 | Sale | $34.15 | 13,779 | 470,526 | 4,951,587 | Nov 13, 2020, 07:47 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 12, 2020 | Sale | $34.15 | 1,819 | 62,116 | 986,512 | Nov 13, 2020, 07:47 PM |
Bolzon Bradley J PhD | Director | Nov 12, 2020 | Sale | $34.15 | 15,598 | 532,642 | 4,951,587 | Nov 13, 2020, 07:46 PM |
Roberts Christopher D. | Chief Scientific Officer | Nov 11, 2020 | Option Exercise | $10.86 | 5,000 | 54,300 | 5,000 | Nov 13, 2020, 04:26 PM |
Roberts Christopher D. | Chief Scientific Officer | Nov 11, 2020 | Sale | $34.90 | 5,000 | 174,500 | 0 | Nov 13, 2020, 04:26 PM |
Hatzis-Schoch Brent | See Remarks | Nov 12, 2020 | Option Exercise | $3.20 | 4,078 | 13,050 | 7,078 | Nov 13, 2020, 04:25 PM |
Hatzis-Schoch Brent | See Remarks | Nov 12, 2020 | Sale | $33.99 | 4,078 | 138,607 | 5,511 | Nov 13, 2020, 04:25 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 11, 2020 | Sale | $34.73 | 11,146 | 387,127 | 5,655,404 | Nov 12, 2020, 05:41 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 11, 2020 | Sale | $34.73 | 1,471 | 51,091 | 988,227 | Nov 12, 2020, 05:41 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 10, 2020 | Sale | $33.83 | 23,821 | 805,755 | 5,669,956 | Nov 12, 2020, 05:41 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 10, 2020 | Sale | $33.83 | 3,145 | 106,381 | 990,149 | Nov 12, 2020, 05:41 PM |
Bolzon Bradley J PhD | Director | Nov 11, 2020 | Sale | $34.73 | 12,617 | 438,217 | 5,655,404 | Nov 12, 2020, 05:38 PM |
Bolzon Bradley J PhD | Director | Nov 10, 2020 | Sale | $33.83 | 26,966 | 912,136 | 5,669,956 | Nov 12, 2020, 05:38 PM |
Leggett Thomas | Chief Financial Officer | Nov 09, 2020 | Option Exercise | $10.86 | 3,000 | 32,580 | 3,000 | Nov 12, 2020, 05:00 PM |
Leggett Thomas | Chief Financial Officer | Nov 09, 2020 | Sale | $32.96 | 3,000 | 98,892 | 0 | Nov 12, 2020, 05:00 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 06, 2020 | Sale | $33.13 | 2,738 | 90,706 | 5,686,909 | Nov 10, 2020, 07:24 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 06, 2020 | Sale | $33.13 | 362 | 11,993 | 992,387 | Nov 10, 2020, 07:24 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 09, 2020 | Sale | $33.06 | 5,565 | 183,954 | 5,681,344 | Nov 10, 2020, 07:24 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 09, 2020 | Sale | $33.06 | 735 | 24,296 | 991,652 | Nov 10, 2020, 07:24 PM |
Bolzon Bradley J PhD | Director | Nov 09, 2020 | Sale | $33.06 | 6,300 | 208,250 | 5,681,344 | Nov 10, 2020, 07:24 PM |
Bolzon Bradley J PhD | Director | Nov 06, 2020 | Sale | $33.13 | 3,100 | 102,698 | 5,686,909 | Nov 10, 2020, 07:24 PM |
Bolzon Bradley J PhD | Director | Nov 05, 2020 | Sale | $33.15 | 8,848 | 293,287 | 5,689,647 | Nov 06, 2020, 04:49 PM |
Bolzon Bradley J PhD | Director | Nov 04, 2020 | Sale | $33.14 | 2,500 | 82,839 | 5,697,463 | Nov 06, 2020, 04:49 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 04, 2020 | Sale | $33.14 | 292 | 9,676 | 993,781 | Nov 06, 2020, 04:44 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 05, 2020 | Sale | $33.15 | 7,816 | 259,079 | 5,689,647 | Nov 06, 2020, 04:44 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 05, 2020 | Sale | $33.15 | 1,032 | 34,208 | 992,749 | Nov 06, 2020, 04:44 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Nov 04, 2020 | Sale | $33.14 | 2,208 | 73,164 | 5,697,463 | Nov 06, 2020, 04:44 PM |
Roberts Christopher D. | Chief Scientific Officer | Nov 03, 2020 | Option Exercise | $10.86 | 2,500 | 27,150 | 2,500 | Nov 04, 2020, 08:37 PM |
Roberts Christopher D. | Chief Scientific Officer | Nov 03, 2020 | Sale | $31.95 | 2,500 | 79,873 | 0 | Nov 04, 2020, 08:37 PM |
Epstein David M. | See Remarks | Nov 02, 2020 | Option Exercise | $6.42 | 3,000 | 19,260 | 723,923 | Nov 03, 2020, 07:56 PM |
Epstein David M. | See Remarks | Nov 02, 2020 | Sale | $31.14 | 12,000 | 373,656 | 712,006 | Nov 03, 2020, 07:56 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 26, 2020 | Sale | $33.30 | 7,158 | 238,394 | 5,700,378 | Oct 28, 2020, 05:58 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 26, 2020 | Sale | $33.30 | 945 | 31,473 | 994,166 | Oct 28, 2020, 05:58 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 27, 2020 | Sale | $33.03 | 707 | 23,354 | 5,699,671 | Oct 28, 2020, 05:58 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 27, 2020 | Sale | $33.03 | 93 | 3,072 | 994,073 | Oct 28, 2020, 05:58 PM |
Bolzon Bradley J PhD | Director | Oct 27, 2020 | Sale | $33.03 | 800 | 26,426 | 5,699,671 | Oct 28, 2020, 05:51 PM |
Bolzon Bradley J PhD | Director | Oct 26, 2020 | Sale | $33.30 | 8,103 | 269,867 | 5,700,378 | Oct 28, 2020, 05:51 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 16, 2020 | Sale | $33.57 | 7,697 | 258,410 | 5,711,275 | Oct 20, 2020, 08:09 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 16, 2020 | Sale | $33.57 | 1,016 | 34,110 | 995,605 | Oct 20, 2020, 08:09 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 15, 2020 | Sale | $33.03 | 2,473 | 81,694 | 5,718,972 | Oct 20, 2020, 08:09 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 15, 2020 | Sale | $33.03 | 327 | 10,802 | 996,621 | Oct 20, 2020, 08:09 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 19, 2020 | Sale | $33.43 | 3,739 | 124,998 | 5,707,536 | Oct 20, 2020, 08:09 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 19, 2020 | Sale | $33.43 | 494 | 16,515 | 995,111 | Oct 20, 2020, 08:09 PM |
Bolzon Bradley J PhD | Director | Oct 19, 2020 | Sale | $33.43 | 4,233 | 141,513 | 5,707,536 | Oct 20, 2020, 08:03 PM |
Bolzon Bradley J PhD | Director | Oct 16, 2020 | Sale | $33.57 | 8,713 | 292,520 | 5,711,275 | Oct 20, 2020, 08:03 PM |
Bolzon Bradley J PhD | Director | Oct 15, 2020 | Sale | $33.03 | 2,800 | 92,496 | 5,718,972 | Oct 20, 2020, 08:03 PM |
Bolzon Bradley J PhD | Director | Oct 14, 2020 | Sale | $33.09 | 5,501 | 182,031 | 5,721,445 | Oct 15, 2020, 07:26 PM |
Bolzon Bradley J PhD | Director | Oct 13, 2020 | Sale | $33.39 | 11,739 | 391,984 | 5,726,304 | Oct 15, 2020, 07:26 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 14, 2020 | Sale | $33.09 | 4,859 | 160,787 | 5,721,445 | Oct 15, 2020, 07:22 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 14, 2020 | Sale | $33.09 | 642 | 21,244 | 996,948 | Oct 15, 2020, 07:22 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 13, 2020 | Sale | $33.39 | 10,370 | 346,271 | 5,726,304 | Oct 15, 2020, 07:22 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 13, 2020 | Sale | $33.39 | 1,369 | 45,713 | 997,590 | Oct 15, 2020, 07:22 PM |
Hatzis-Schoch Brent | See Remarks | Oct 12, 2020 | Option Exercise | $3.20 | 4,078 | 13,050 | 7,078 | Oct 14, 2020, 04:32 PM |
Hatzis-Schoch Brent | See Remarks | Oct 12, 2020 | Sale | $32.70 | 4,078 | 133,331 | 3,295 | Oct 14, 2020, 04:32 PM |
Bolzon Bradley J PhD | Director | Oct 12, 2020 | Sale | $33.11 | 400 | 13,243 | 5,736,674 | Oct 13, 2020, 07:48 PM |
Bolzon Bradley J PhD | Director | Oct 09, 2020 | Sale | $33.67 | 3,800 | 127,933 | 5,737,027 | Oct 13, 2020, 07:48 PM |
Bolzon Bradley J PhD | Director | Oct 08, 2020 | Sale | $33.47 | 18,425 | 616,748 | 5,748,886 | Oct 13, 2020, 07:48 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 09, 2020 | Sale | $33.67 | 3,357 | 113,018 | 5,737,027 | Oct 13, 2020, 07:41 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 09, 2020 | Sale | $33.67 | 443 | 14,914 | 999,006 | Oct 13, 2020, 07:41 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 08, 2020 | Sale | $33.47 | 16,276 | 544,814 | 5,748,886 | Oct 13, 2020, 07:41 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 08, 2020 | Sale | $33.47 | 2,149 | 71,934 | 1,000,571 | Oct 13, 2020, 07:41 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 12, 2020 | Sale | $33.11 | 353 | 11,687 | 5,736,674 | Oct 13, 2020, 07:41 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 12, 2020 | Sale | $33.11 | 47 | 1,556 | 998,959 | Oct 13, 2020, 07:41 PM |
Leggett Thomas | Chief Financial Officer | Oct 08, 2020 | Option Exercise | $10.86 | 3,000 | 32,580 | 3,000 | Oct 09, 2020, 04:12 PM |
Leggett Thomas | Chief Financial Officer | Oct 08, 2020 | Sale | $33.53 | 3,000 | 100,576 | 0 | Oct 09, 2020, 04:12 PM |
Bolzon Bradley J PhD | Director | Oct 07, 2020 | Sale | $33.56 | 27,836 | 934,079 | 5,756,660 | Oct 08, 2020, 07:14 PM |
Bolzon Bradley J PhD | Director | Oct 06, 2020 | Sale | $33.26 | 18,090 | 601,653 | 5,781,250 | Oct 08, 2020, 07:14 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 07, 2020 | Sale | $33.56 | 24,590 | 825,154 | 5,756,660 | Oct 08, 2020, 07:14 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 07, 2020 | Sale | $33.56 | 3,246 | 108,924 | 1,041,206 | Oct 08, 2020, 07:14 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 06, 2020 | Sale | $33.26 | 15,980 | 531,477 | 5,781,250 | Oct 08, 2020, 07:14 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Oct 06, 2020 | Sale | $33.26 | 2,110 | 70,176 | 1,044,452 | Oct 08, 2020, 07:14 PM |
Roberts Christopher D. | Chief Scientific Officer | Oct 05, 2020 | Option Exercise | $10.86 | 2,500 | 27,150 | 2,500 | Oct 07, 2020, 04:27 PM |
Roberts Christopher D. | Chief Scientific Officer | Oct 05, 2020 | Sale | $31.28 | 2,500 | 78,188 | 227 | Oct 07, 2020, 04:27 PM |
Epstein David M. | See Remarks | Oct 01, 2020 | Option Exercise | $6.42 | 3,000 | 19,260 | 732,923 | Oct 02, 2020, 05:07 PM |
Epstein David M. | See Remarks | Oct 01, 2020 | Sale | $30.33 | 12,000 | 363,962 | 720,923 | Oct 02, 2020, 05:07 PM |
INGRAM ROBERT ALEXANDER | Director | Sep 30, 2020 | Buy | $30.46 | 5,000 | 152,285 | 5,000 | Oct 01, 2020, 04:06 PM |
Hatzis-Schoch Brent | See Remarks | Sep 14, 2020 | Option Exercise | $3.20 | 4,078 | 13,050 | 7,078 | Sep 16, 2020, 06:11 PM |
Hatzis-Schoch Brent | See Remarks | Sep 14, 2020 | Sale | $31.04 | 4,078 | 126,583 | 4,393 | Sep 16, 2020, 06:11 PM |
Leggett Thomas | Chief Financial Officer | Sep 14, 2020 | Option Exercise | $10.86 | 3,000 | 32,580 | 3,000 | Sep 16, 2020, 06:09 PM |
Leggett Thomas | Chief Financial Officer | Sep 14, 2020 | Sale | $31.00 | 3,000 | 93,000 | 0 | Sep 16, 2020, 06:09 PM |
Roberts Christopher D. | Chief Scientific Officer | Sep 03, 2020 | Option Exercise | $10.86 | 2,500 | 27,150 | 2,500 | Sep 04, 2020, 05:27 PM |
Roberts Christopher D. | Chief Scientific Officer | Sep 03, 2020 | Sale | $29.59 | 2,500 | 73,987 | 2,358 | Sep 04, 2020, 05:27 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Aug 10, 2020 | Sale | $33.04 | 5,492 | 181,446 | 6,803,922 | Aug 12, 2020, 07:57 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Aug 10, 2020 | Sale | $33.04 | 725 | 23,953 | 1,126,661 | Aug 12, 2020, 07:57 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Aug 11, 2020 | Sale | $33.08 | 6,692 | 221,380 | 6,797,230 | Aug 12, 2020, 07:57 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Aug 11, 2020 | Sale | $33.08 | 883 | 29,211 | 1,125,778 | Aug 12, 2020, 07:57 PM |
Bolzon Bradley J PhD | Director | Aug 11, 2020 | Sale | $33.08 | 7,575 | 250,591 | 6,797,230 | Aug 12, 2020, 07:46 PM |
Bolzon Bradley J PhD | Director | Aug 10, 2020 | Sale | $33.04 | 6,217 | 205,398 | 6,803,922 | Aug 12, 2020, 07:46 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Feb 03, 2020 | Buy | $19.00 | 396,082 | 7,525,558 | 6,809,414 | Feb 05, 2020, 06:02 PM |
Versant Venture Capital VI, L.P. | 10% Owner | Feb 03, 2020 | Buy | $19.00 | 498,654 | 9,474,426 | 2,209,592 | Feb 05, 2020, 06:02 PM |
Bolzon Bradley J PhD | Director | Feb 03, 2020 | Buy | $19.00 | 894,736 | 16,999,984 | 6,809,414 | Feb 05, 2020, 05:59 PM |
Shah Rajeev M. | Director | Feb 03, 2020 | Buy | $19.00 | 1,000,000 | 19,000,000 | 1,924,164 | Feb 05, 2020, 05:58 PM |
Hatzis-Schoch Brent | See Remarks | Feb 03, 2020 | Buy | $19.00 | 3,000 | 57,000 | 3,000 | Feb 05, 2020, 05:55 PM |
Behbahani Ali | Director | Feb 03, 2020 | Buy | $19.00 | 800,000 | 15,200,000 | 3,448,757 | Feb 05, 2020, 05:55 PM |
Flynn James E | 10% Owner | Feb 03, 2020 | Buy | $19.00 | 400,000 | 7,600,000 | 778,790 | Feb 03, 2020, 01:25 PM |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 3,525,754 | 0.15% | No change | Other |
BLACKROCK INC. | 1,350,047 | 0.0001% | -3.58% | Other |
DRIEHAUS CAPITAL MANAGEMENT LLC | 696,969 | 0.02% | No change | Growth |
CANDRIAM S.C.A. | 540,009 | 0.01% | 8% | Other |
RENAISSANCE TECHNOLOGIES LLC | 450,400 | 0.00196% | 36.94% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 350,446 | 0.0001% | 8.07% | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View